1-3 of 3
risk management
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk Management Indicators in Patients with Lymphoma in Colombia

Paula Ramírez, MD MPH, Ana Milena Gil, MSc, Juan Camilo Fuentes, MD MSc, Claudia Lucia Sossa, Claudia Marcela Chalela, MD, Jose Sandoval-Sus, MD, Lizbeth Alexandra Acuña, PhD MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 5852.
https://doi.org/10.1182/blood-2018-99-120347
Published: 2018
Journal Articles

Comprehensive Analysis of Safety: Rigosertib in 557 Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Guillermo Garcia-Manero, MD, Pierre Fenaux, MD PhD, Aref Al-Kali, MD, Shyamala C. Navada, MD, Maria R. Baer, MD, Azra Raza, MD, Peter Greenberg, MD, Karl-Anton Kreuzer, MD, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD, Gail J. Roboz, Valeria Santini, MD, Uwe Platzbecker, MD, Michael E. Petrone, MD MPH, Bernard Brownstein, MD, Patrick Simon Zbyszewski, MBA, Manoj Maniar, PhD, Lewis R. Silverman, MD
Journal: Blood
Blood (2016) 128 (22): 2011.
https://doi.org/10.1182/blood.V128.22.2011.2011
Published: 2016
Journal Articles

Patient Safety in the Context of Disease Outcome and Effectiveness of Therapy.

Marlies E.H.M. Van Hoef, MD, PhD, MBA
Journal: Blood
Blood (2007) 110 (11): 4959.
https://doi.org/10.1182/blood.V110.11.4959.4959
Published: 2007